TriArm Therapeutics is a specialized cell therapy corporation founded by Panacea Venture with research and development facilities in Germany, the United States, and the Greater China region. The company's primary objective is to investigate and clinically transform CD19 CAR-T products utilizing non-viral gene transfer technology. This innovative approach significantly reduces the cost and duration of cell therapy product manufacturing, ultimately leading to improved cancer treatment outcomes.

Disease Domain	Count

Neoplasms	15
Hemic and Lymphatic Diseases	9
Immune System Diseases	6

Top 5 Drug Type	Count

CAR-T	10
Cell therapy	3
Autologous CAR-T	1
TCR therapy	1

Top 5 Target	Count

CD20 x CD30	1
CD70(CD70 antigen)	1
HER2(Receptor tyrosine-protein kinase erbB-2)	1
CD30(Tumor necrosis factor receptor superfamily member 8)	1
Integrin	1

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 10 Mar 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

Preclinical

IND Application

IND Approval

Phase 1

Current Projects

Drug(Targets)	Indications	Global Highest Phase

RPM CD19-mbIL15-CAR-T cells ( CD19 x IL-15 )	B-Cell Leukemia More	Phase 1
ARM004	Solid tumor More	Early Phase 1
ARM001	Hematologic Neoplasms More	Early Phase 1
FIT-CD19 ( CD19 )	Non-Hodgkin Lymphoma More	IND Approval
ARM-003	Hematologic Neoplasms More	IND Application

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis